| CIR Circadian Technologies Changes Name to Opthea |
| 11/12/15 | | 46.88KB | Share |
|
| CIR Initial Director's Interest Notice - MS |
| 04/12/15 | | 85.4KB | Share |
|
| CIR Initial Director's Interest Notice - GK |
| 04/12/15 | | 64.47KB | Share |
|
| CIR Final Director's Interest Notice - TM |
| 04/12/15 | | 63.9KB | Share |
|
| CIR Final Director's Interest Notice - RH |
| 04/12/15 | | 63.27KB | Share |
|
| CIR Final Director's Interest Notice - DF |
| 04/12/15 | | 64.68KB | Share |
|
| CIR Circadian Receives $3M R&D Tax Incentive |
| 02/12/15 | PRICE SENSITIVE | 45.4KB | Share |
|
| CIR Circadian Board Changes and Renewal |
| 30/11/15 | PRICE SENSITIVE | 258.54KB | Share |
|
| CIR Results of the Annual General Meeting |
| 30/11/15 | | 54.72KB | Share |
|
| CIR CEO Presentation for the Annual General Meeting |
| 30/11/15 | | 1.89MB | Share |
|
| CIR Chairman's address to the Annual General Meeting |
| 30/11/15 | | 66.46KB | Share |
|
| CIR Trading Halt |
| 30/11/15 | PRICE SENSITIVE | 257.45KB | Share |
|
| CIR Circadian/Opthea presentation at OIS 2015 |
| 13/11/15 | | 1.38MB | Share |
|
| CIR Circadian to Present at US Ophthalmology Innovation Summit |
| 10/11/15 | | 267.11KB | Share |
|
| CIR Notice of Annual General Meeting and Proxy Form |
| 30/10/15 | | 765.9KB | Share |
|
| CIR Circadian to regain VEGFR-3 intellectual property license |
| 23/10/15 | PRICE SENSITIVE | 47.36KB | Share |
|
| CIR Appendix 4G |
| 30/09/15 | | 130.3KB | Share |
|
| CIR Annual Report 2015 |
| 30/09/15 | | 1.06MB | Share |
|
| CIR Change in substantial holding |
| 07/09/15 | | 233.88KB | Share |
|
| CIR Appendix 4E and Annual Financial Report 2015 |
| 19/08/15 | PRICE SENSITIVE | 935.84KB | Share |
|
| CIR Circadian Corporate Presentation - July 2015 |
| 09/07/15 | | 1.89MB | Share |
|
| CIR Change of Director's Interest Notice - DF |
| 02/07/15 | | 76.67KB | Share |
|
| CIR Change of Director's Interest Notice - MB |
| 02/07/15 | | 73.44KB | Share |
|
| CIR Appendix 3B |
| 02/07/15 | | 233.75KB | Share |
|
| CIR Circadian Commences Wet AMD OPT-302 Clinical Trial |
| 01/07/15 | PRICE SENSITIVE | 256.43KB | Share |
|
| CIR Change in substantial holding |
| 25/06/15 | | 141.68KB | Share |
|
| CIR Circadian receives IND approval from FDA for Wet AMD Phase 1 |
| 15/06/15 | PRICE SENSITIVE | 257.43KB | Share |
|
| CIR Circadian partner Eli Lilly presents IMC-3C5 Ph1 at ASCO |
| 02/06/15 | PRICE SENSITIVE | 829.98KB | Share |
|
| CIR OPT-302 Data Presented at Major Ophthalmology Conferences |
| 07/05/15 | | 167.63KB | Share |
|
| CIR Circadian Shareholder Newsletter April 2015 |
| 16/04/15 | | 850.85KB | Share |
|
| CIR Half Year Report and Accounts |
| 26/02/15 | PRICE SENSITIVE | 571.22KB | Share |
|
| CIR US Patent Granted for Soluble VEGFR-3 Traps |
| 28/01/15 | PRICE SENSITIVE | 179.31KB | Share |
|
| CIR Circadian Receives $2.2M R&D Tax Incentive |
| 23/01/15 | PRICE SENSITIVE | 38.07KB | Share |
|
| CIR Appendix 3B |
| 15/01/15 | | 151.76KB | Share |
|
| CIR Change of Director's Interest Notice - DF |
| 23/12/14 | | 76.68KB | Share |
|
| CIR Change of Director's Interest Notice - MB |
| 23/12/14 | | 74.31KB | Share |
|
| CIR Appendix 3B |
| 23/12/14 | | 157.61KB | Share |
|
| CIR Circadian Announces Formation of Clinical Advisory Board |
| 03/12/14 | | 251.52KB | Share |
|
| CIR Ceasing to be a substantial holder |
| 27/11/14 | | 110.09KB | Share |
|
| CIR Placement Cleansing Notice |
| 27/11/14 | | 53.31KB | Share |
|
| CIR Becoming a substantial holder |
| 26/11/14 | | 608.53KB | Share |
|
| CIR Completion of Placement and Appendix 3B |
| 25/11/14 | | 199.36KB | Share |
|
| CIR Change in substantial holding |
| 25/11/14 | | 135.33KB | Share |
|
| CIR Becoming a substantial holder |
| 25/11/14 | | 8.26MB | Share |
|
| CIR Change of Director's Interest Notice |
| 20/11/14 | | 74.25KB | Share |
|
| CIR Change of Director's Interest Notice |
| 20/11/14 | | 71.54KB | Share |
|
| CIR Change of Director's Interest Notice |
| 19/11/14 | | 74.12KB | Share |
|
| CIR Change of Director's Interest Notice |
| 19/11/14 | | 74.36KB | Share |
|
| PER News Report Misinterprets Substantial Notice |
| 18/11/14 | | 33.9KB | Share |
|
| CIR Results of Annual General Meeting |
| 18/11/14 | | 55.47KB | Share |
|
| CIR CEO's address to Annual General Meeting |
| 18/11/14 | | 1.45MB | Share |
|
| CIR Chairman's Address to Annual General Meeting |
| 18/11/14 | | 47.35KB | Share |
|
| PER Change in substantial holding from CIR |
| 17/11/14 | | 72.02KB | Share |
|
| CIR Change in substantial holding |
| 14/11/14 | | 112.45KB | Share |
|
| CIR Circadian Appendix 3B |
| 12/11/14 | | 177.62KB | Share |
|
| CIR Completion of Rights Issue |
| 06/11/14 | | 42.62KB | Share |
|
| CIR Becoming a substantial holder |
| 24/10/14 | | 70.73KB | Share |
|
| CIR Placement Cleansing Notice |
| 22/10/14 | | 53.13KB | Share |
|
| CIR Circadian Appendix 3B |
| 22/10/14 | | 158.83KB | Share |
|
| CIR Circadian Annual General Meeting 2014 |
| 17/10/14 | | 643.55KB | Share |
|
| CIR Circadian Letter to Shareholders |
| 10/10/14 | | 103.46KB | Share |
|
| CIR Circadian Capital Raising Prospectus |
| 09/10/14 | PRICE SENSITIVE | 386.11KB | Share |
|
| CIR Circadian Investor Presentation |
| 06/10/14 | | 1.39MB | Share |
|
| CIR CIR Appendix 3B |
| 06/10/14 | | 155.21KB | Share |
|
| CIR Circadian to Raise A$17.4 Million |
| 06/10/14 | PRICE SENSITIVE | 210.63KB | Share |
|
| CIR Request for Trading Halt |
| 01/10/14 | | 43.37KB | Share |
|
| CIR Trading Halt |
| 01/10/14 | PRICE SENSITIVE | 113.55KB | Share |
|
| CIR Annual Report 2014 |
| 30/09/14 | | 2.52MB | Share |
|
| CIR Circadian Allowed Key Patent for VEGFR-3 Traps in US |
| 23/09/14 | PRICE SENSITIVE | 177.09KB | Share |
|
| CIR Preliminary Final Report |
| 29/08/14 | PRICE SENSITIVE | 263.21KB | Share |
|
| CIR Opthea Awarded Grant for OPT-302 Manufacture |
| 23/06/14 | PRICE SENSITIVE | 125.98KB | Share |
|
| CIRCircadian's VGX-100 Well Tolerated in Phase 1 Clinical Trial |
| 02/06/14 | | 302.44KB | Share |
|
| CIRCircadian Appoints CFO and Company Secretary |
| 19/05/14 | | 86.47KB | Share |
|
| CIRVGX-100 Phase 1 Study Selected for Presentation at ASCO 2014 |
| 15/05/14 | | 154.75KB | Share |
|
| CIROpthea Completes Pre-IND Meeting with FDA |
| 12/05/14 | PRICE SENSITIVE | 130.88KB | Share |
|
| CIROPT-302 reduces established wet AMD lesions in the mouse |
| 06/05/14 | PRICE SENSITIVE | 678.8KB | Share |
|
| CIRCEO Terms of Employment |
| 23/04/14 | PRICE SENSITIVE | 202.72KB | Share |
|
| CIRHalf Year Report & Accounts |
| 21/02/14 | PRICE SENSITIVE | 1.06MB | Share |
|
| CIRCircadian Appoints CEO and Managing Director |
| 21/02/14 | PRICE SENSITIVE | 260.43KB | Share |
|
| CIROpthea Signs Cell Line Commercial License Agreement |
| 14/01/14 | PRICE SENSITIVE | 574.45KB | Share |
|
| CIRAppendix 3Z - Final Directors Interest Notice |
| 10/12/13 | | 13.35KB | Share |
|
| CIRAppendix 3X - Initial Directors Interest Notice |
| 06/12/13 | | 69.33KB | Share |
|
| CIRCircadian CEO and Board Changes |
| 03/12/13 | PRICE SENSITIVE | 21.25KB | Share |
|
| CIRResults of Annual General Meeting |
| 29/11/13 | | 24.43KB | Share |
|
| CIRCEOs Address To Annual General Meeting |
| 29/11/13 | | 1.37MB | Share |
|
| CIRChairmans Address To Annual General Meeting |
| 29/11/13 | | 33.79KB | Share |
|
| CIRAppendix 3Z - Final Directors Interest Notice |
| 29/11/13 | | 11.63KB | Share |
|
| CIRDirector Resignation |
| 29/11/13 | | 21.22KB | Share |
|
| CIRPhase 1b oncology trial completed |
| 27/11/13 | PRICE SENSITIVE | 371.7KB | Share |
|
| CIRR&D Tax Incentive - Circadian To Receive Over $2.5m |
| 15/11/13 | PRICE SENSITIVE | 51.05KB | Share |
|
| CIROpthea Signs Manufacturing Agreement |
| 30/10/13 | PRICE SENSITIVE | 471.6KB | Share |
|
| CIRAnnual Report / Notice of AGM & Proxy Form |
| 28/10/13 | | 6.53MB | Share |
|
| CIRPhase 1a clinical oncology trial with VGX-100 update |
| 17/10/13 | PRICE SENSITIVE | 110.33KB | Share |
|
| CIR Change in substantial holding from CIR |
| 08/10/13 | | 132.18KB | Share |
|
| CIRRevised AGM Details |
| 01/10/13 | | 23.45KB | Share |
|
| CIRAnalyst Investment Report on Circadian Website |
| 11/09/13 | | 49.76KB | Share |
|
| CIRNew Compamy Secretary |
| 10/09/13 | | 44.43KB | Share |
|
| CIROpen Briefing |
| 28/08/13 | PRICE SENSITIVE | 288.12KB | Share |
|
| CIRPreliminary Final Report |
| 27/08/13 | PRICE SENSITIVE | 648.19KB | Share |
|
| CIRCircadian moves to new South Yarra office |
| 15/07/13 | | 96.56KB | Share |
|
